Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer

• Prif Awduron: Jie Yao (Awdur), Xuwen Lin (Awdur), Xin Zhang (Awdur), Mei Xie (Awdur), Xidong Ma (Awdur), Xinyu Bao (Awdur), Jialin Song (Awdur), Yiran Liang (Awdur), Qiqi Wang (Awdur), Xinying Xue (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Immune checkpoint inhibitors (ICIs) have changed the treatment mode of lung cancer, extending the survival time of patients unprecedentedly. Once patients respond to ICIs, the median duration of response is usually longer than that achieved with cytotoxic or targeted drugs. Unfortunately, there is s...